TTC37 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.474200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.880200E-01
Normal-vs-Stage2
5.573000E-01
Normal-vs-Stage3
5.140100E-02
Normal-vs-Stage4
4.196800E-01
Stage1-vs-Stage2
5.357700E-02
Stage1-vs-Stage3
1.988240E-02
Stage1-vs-Stage4
8.215400E-01
Stage2-vs-Stage3
1.935190E-01
Stage2-vs-Stage4
6.079600E-02
Stage3-vs-Stage4
2.303800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.642000E-01
Normal-vs-AfricanAmerican
9.884800E-01
Normal-vs-Asian
1.557200E-01
Caucasian-vs-AfricanAmerican
6.584400E-01
Caucasian-vs-Asian
6.886200E-02
AfricanAmerican-vs-Asian
1.220040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.340000E-01
Normal-vs-Female
7.748600E-01
Male-vs-Female
8.153800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.904600E-01
Normal-vs-Age(41-60Yrs)
9.674600E-01
Normal-vs-Age(61-80Yrs)
6.355200E-01
Normal-vs-Age(81-100Yrs)
5.088000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.761800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.279200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.047200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.071900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.960420E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.168800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.036000E-01
Normal-vs-Daily Drinker
2.068600E-01
Normal-vs-Weekly Drinker
4.784200E-01
Normal-vs-Occasional Drinker
8.372800E-01
Normal-vs-Social Drinker
8.416400E-01
Non Drinker-vs-Daily Drinker
6.016800E-01
Non Drinker-vs-Weekly Drinker
5.670200E-01
Non Drinker-vs-Occasional Drinker
4.562100E-02
Non Drinker-vs-Social Drinker
9.221900E-02
Daily Drinker-vs-Weekly Drinker
3.898400E-01
Daily Drinker-vs-Occasional Drinker
2.138100E-02
Daily Drinker-vs-Social Drinker
6.254100E-02
Weekly Drinker-vs-Occasional Drinker
1.787420E-01
Weekly Drinker-vs-Social Drinker
2.179600E-01
Occasional Drinker-vs-Social Drinker
9.697000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.042200E-01
Normal-vs-Grade 2
2.058000E-01
Normal-vs-Grade 3
1.553240E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.487800E-01
Grade 1-vs-Grade 3
6.195600E-01
Grade 1-vs-Grade 4
4.042200E-01
Grade 2-vs-Grade 3
5.991800E-01
Grade 2-vs-Grade 4
2.058000E-01
Grade 3-vs-Grade 4
1.553240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.936800E-01
Normal-vs-NonDiabetic
6.855000E-01
Diabetic-vs-NonDiabetic
6.462200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.925380E-01
Normal-vs-NoPancreatitis
7.215800E-01
Pancreatitis-vs-NoPancreatitis
1.399950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.590800E-01
Normal-vs-N1
5.808000E-01
N0-vs-N1
2.895800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.871800E-01
Normal-vs-TP53-NonMutant
7.939400E-01
TP53-Mutant-vs-TP53-NonMutant
3.551700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
